---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033119"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2024-08-19T23:59:59+00:00"
generated_at: "2026-05-31T08:45:16.070223+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics sets 2024 annual meeting for Sept 27; proposal deadline Aug 29

## Summary
- Annual meeting scheduled for September 27, 2024.
- Stockholder proposals and nominations must be received by August 29, 2024.
- Date is >30 days from 2023 annual meeting anniversary, triggering special notice timeline.
- All notices must be directed to company's principal executive offices per bylaws.

## SEC filing metadata
- accession: 0001493152-24-033119
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2024-08-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315224033119/0001493152-24-033119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315224033119/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033119
- JSON: https://secwatch.observer/filing/0001493152-24-033119.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.